Report Detail
Global Non-insulin Diabetes Therapeutics Market Size, Status and Forecast 2019-2025
- RnM3476042 |
- 04 July, 2019 |
- Global |
- 107 Pages |
- QYResearch |
- Other
Non-insulin diabetes therapeutics are mostly administered orally and prescribed when diet and exercise are insufficient to control elevated blood glucose levels.
In 2018, the global Non-insulin Diabetes Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Non-insulin Diabetes Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Non-insulin Diabetes Therapeutics development in United States, Europe and China.
The key players covered in this study
GSK
Eli Lilly
Sumitomo Dainippon Pharma
Intarcia Therapeutics
Servier
Jiangsu Hansoh Pharmaceutical
Novo Nordisk
Emisphere
Uni-Bio Science Group
Takeda
3SBio
Merck
Dong-A Pharmaceutical
Luye Pharma Group
Eurofarma
Geropharm
Alkem Labs
SatRx
Pfizer
Market segment by Type, the product can be split into
DPP4 inhibitor
GLP-1 agonist
SGLT2 inhibitor
Market segment by Application, split into
Hospital Pharmacy
Retail Pharmacies
Online Pharmacy
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Non-insulin Diabetes Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Non-insulin Diabetes Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Non-insulin Diabetes Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Non-insulin Diabetes Therapeutics Market Size Growth Rate by Type (2014-2025)
- 1.4.2 DPP4 inhibitor
- 1.4.3 GLP-1 agonist
- 1.4.4 SGLT2 inhibitor
- 1.5 Market by Application
- 1.5.1 Global Non-insulin Diabetes Therapeutics Market Share by Application (2014-2025)
- 1.5.2 Hospital Pharmacy
- 1.5.3 Retail Pharmacies
- 1.5.4 Online Pharmacy
- 1.5.5 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Non-insulin Diabetes Therapeutics Market Size
- 2.2 Non-insulin Diabetes Therapeutics Growth Trends by Regions
- 2.2.1 Non-insulin Diabetes Therapeutics Market Size by Regions (2014-2025)
- 2.2.2 Non-insulin Diabetes Therapeutics Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Opportunities
3 Market Share by Key Players
- 3.1 Non-insulin Diabetes Therapeutics Market Size by Manufacturers
- 3.1.1 Global Non-insulin Diabetes Therapeutics Revenue by Manufacturers (2014-2019)
- 3.1.2 Global Non-insulin Diabetes Therapeutics Revenue Market Share by Manufacturers (2014-2019)
- 3.1.3 Global Non-insulin Diabetes Therapeutics Market Concentration Ratio (CR5 and HHI)
- 3.2 Non-insulin Diabetes Therapeutics Key Players Head office and Area Served
- 3.3 Key Players Non-insulin Diabetes Therapeutics Product/Solution/Service
- 3.4 Date of Enter into Non-insulin Diabetes Therapeutics Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Non-insulin Diabetes Therapeutics Market Size by Type (2014-2019)
- 4.2 Global Non-insulin Diabetes Therapeutics Market Size by Application (2014-2019)
5 United States
- 5.1 United States Non-insulin Diabetes Therapeutics Market Size (2014-2019)
- 5.2 Non-insulin Diabetes Therapeutics Key Players in United States
- 5.3 United States Non-insulin Diabetes Therapeutics Market Size by Type
- 5.4 United States Non-insulin Diabetes Therapeutics Market Size by Application
6 Europe
- 6.1 Europe Non-insulin Diabetes Therapeutics Market Size (2014-2019)
- 6.2 Non-insulin Diabetes Therapeutics Key Players in Europe
- 6.3 Europe Non-insulin Diabetes Therapeutics Market Size by Type
- 6.4 Europe Non-insulin Diabetes Therapeutics Market Size by Application
7 China
- 7.1 China Non-insulin Diabetes Therapeutics Market Size (2014-2019)
- 7.2 Non-insulin Diabetes Therapeutics Key Players in China
- 7.3 China Non-insulin Diabetes Therapeutics Market Size by Type
- 7.4 China Non-insulin Diabetes Therapeutics Market Size by Application
8 Japan
- 8.1 Japan Non-insulin Diabetes Therapeutics Market Size (2014-2019)
- 8.2 Non-insulin Diabetes Therapeutics Key Players in Japan
- 8.3 Japan Non-insulin Diabetes Therapeutics Market Size by Type
- 8.4 Japan Non-insulin Diabetes Therapeutics Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Non-insulin Diabetes Therapeutics Market Size (2014-2019)
- 9.2 Non-insulin Diabetes Therapeutics Key Players in Southeast Asia
- 9.3 Southeast Asia Non-insulin Diabetes Therapeutics Market Size by Type
- 9.4 Southeast Asia Non-insulin Diabetes Therapeutics Market Size by Application
10 India
- 10.1 India Non-insulin Diabetes Therapeutics Market Size (2014-2019)
- 10.2 Non-insulin Diabetes Therapeutics Key Players in India
- 10.3 India Non-insulin Diabetes Therapeutics Market Size by Type
- 10.4 India Non-insulin Diabetes Therapeutics Market Size by Application
11 Central & South America
- 11.1 Central & South America Non-insulin Diabetes Therapeutics Market Size (2014-2019)
- 11.2 Non-insulin Diabetes Therapeutics Key Players in Central & South America
- 11.3 Central & South America Non-insulin Diabetes Therapeutics Market Size by Type
- 11.4 Central & South America Non-insulin Diabetes Therapeutics Market Size by Application
12 International Players Profiles
- 12.1 GSK
- 12.1.1 GSK Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Non-insulin Diabetes Therapeutics Introduction
- 12.1.4 GSK Revenue in Non-insulin Diabetes Therapeutics Business (2014-2019)
- 12.1.5 GSK Recent Development
- 12.2 Eli Lilly
- 12.2.1 Eli Lilly Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Non-insulin Diabetes Therapeutics Introduction
- 12.2.4 Eli Lilly Revenue in Non-insulin Diabetes Therapeutics Business (2014-2019)
- 12.2.5 Eli Lilly Recent Development
- 12.3 Sumitomo Dainippon Pharma
- 12.3.1 Sumitomo Dainippon Pharma Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Non-insulin Diabetes Therapeutics Introduction
- 12.3.4 Sumitomo Dainippon Pharma Revenue in Non-insulin Diabetes Therapeutics Business (2014-2019)
- 12.3.5 Sumitomo Dainippon Pharma Recent Development
- 12.4 Intarcia Therapeutics
- 12.4.1 Intarcia Therapeutics Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Non-insulin Diabetes Therapeutics Introduction
- 12.4.4 Intarcia Therapeutics Revenue in Non-insulin Diabetes Therapeutics Business (2014-2019)
- 12.4.5 Intarcia Therapeutics Recent Development
- 12.5 Servier
- 12.5.1 Servier Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Non-insulin Diabetes Therapeutics Introduction
- 12.5.4 Servier Revenue in Non-insulin Diabetes Therapeutics Business (2014-2019)
- 12.5.5 Servier Recent Development
- 12.6 Jiangsu Hansoh Pharmaceutical
- 12.6.1 Jiangsu Hansoh Pharmaceutical Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Non-insulin Diabetes Therapeutics Introduction
- 12.6.4 Jiangsu Hansoh Pharmaceutical Revenue in Non-insulin Diabetes Therapeutics Business (2014-2019)
- 12.6.5 Jiangsu Hansoh Pharmaceutical Recent Development
- 12.7 Novo Nordisk
- 12.7.1 Novo Nordisk Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Non-insulin Diabetes Therapeutics Introduction
- 12.7.4 Novo Nordisk Revenue in Non-insulin Diabetes Therapeutics Business (2014-2019)
- 12.7.5 Novo Nordisk Recent Development
- 12.8 Emisphere
- 12.8.1 Emisphere Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Non-insulin Diabetes Therapeutics Introduction
- 12.8.4 Emisphere Revenue in Non-insulin Diabetes Therapeutics Business (2014-2019)
- 12.8.5 Emisphere Recent Development
- 12.9 Uni-Bio Science Group
- 12.9.1 Uni-Bio Science Group Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Non-insulin Diabetes Therapeutics Introduction
- 12.9.4 Uni-Bio Science Group Revenue in Non-insulin Diabetes Therapeutics Business (2014-2019)
- 12.9.5 Uni-Bio Science Group Recent Development
- 12.10 Takeda
- 12.10.1 Takeda Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 Non-insulin Diabetes Therapeutics Introduction
- 12.10.4 Takeda Revenue in Non-insulin Diabetes Therapeutics Business (2014-2019)
- 12.10.5 Takeda Recent Development
- 12.11 3SBio
- 12.12 Merck
- 12.13 Dong-A Pharmaceutical
- 12.14 Luye Pharma Group
- 12.15 Eurofarma
- 12.16 Geropharm
- 12.17 Alkem Labs
- 12.18 SatRx
- 12.19 Pfizer
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Regions
- 13.2 United States
- 13.3 Europe
- 13.4 China
- 13.5 Japan
- 13.6 Southeast Asia
- 13.7 India
- 13.8 Central & South America
- 13.9 Market Size Forecast by Product (2019-2025)
- 13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Non-insulin Diabetes Therapeutics. Industry analysis & Market Report on Non-insulin Diabetes Therapeutics is a syndicated market report, published as Global Non-insulin Diabetes Therapeutics Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Non-insulin Diabetes Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
